RhCMV Expands CCR5 Memory T Cells and promotes SIV reservoir seeding in the Gut Mucosa
Chrysostomos PerdiosiD, Naveen Suresh Babu, Celeste D. Coleman, Anna T. Brown, Matilda J. MoströmiD, Carolina AllersiD, Lara A. Doyle‐MeyersiD, Christine M. FennesseyiD, Brandon F. KeeleiD, Amitinder KauriD, Michael L. FreemaniD, Joseph C. Mudd
Abstract
Cytomegalovirus (CMV) is a prevalent {beta}-herpesvirus that persists asymptomatically in immunocompetent hosts. In people with HIV-1 (PWH), CMV is associated with persistence of the HIV-1 reservoir and particular inflammatory related co-morbidities. The true causative role of CMV in HIV-associated pathologies remains unclear given that nearly all PWH are coinfected with CMV. In this study, we examined acute phase SIV dynamics in cohorts of rhesus macaques that were seropositive or -negative for rhesus CMV (RhCMV). We observed expansion of CCR5+ target CD4+ T cells in gut and lymph nodes (LN) that existed naturally in RhCMV-seropositive animals, the majority of which did not react to RhCMV lysate. These cells expressed high levels of the chemokine receptor CXCR3 and a ligand for this receptor, CXCL9, was systemically elevated in RhCMV-seropositive animals. RhCMV+ RMs also exhibited higher peak SIV viremia. CCR5 target memory CD4 T cells in the gut of RhCMV+ RMs were maintained during acute SIV and this was associated with greater seeding of SIV DNA in the intestine. Overall, our data suggests the ability of RhCMV to regulate chemotactic axes that direct lymphocyte trafficking and promote seeding of SIV in a diverse, polyclonal pool of memory CD4+ T cells.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Modulation of MHC-E transport by viral decoy ligands is required for RhCMV/SIV vaccine efficacy
M. Verweij, S. G. Hansen, … K. Früh·bioRxiv·Sep 30, 2020
- Sustained IL-15 response signature predicts RhCMV/SIV vaccine efficacy
Fredrik Barrenäs, Scott G. Hansen, … Michael Gale·bioRxiv·Jan 11, 2021
- Cytomegaloviral determinants of CD8+ T cell programming and RhCMV/SIV vaccine efficacy
D. Malouli, S. G. Hansen, … L. J. Picker·Science ImmunologyPeer-reviewed·Mar 4, 2021
- Rhesus Cytomegalovirus-encoded Fcγ-binding glycoproteins facilitate viral evasion from IgG-mediated humoral immunity
Claire E. Otero, Sophia Petkova, … Philipp Kolb·Nature CommunicationsPeer-reviewed·Jan 30, 2025
- Protective effect of pre-existing natural immunity in a nonhuman primate reinfection model of congenital cytomegalovirus infection
M. J. Mostrom, S. Yu, … A. Kaur·bioRxiv·Apr 10, 2023
- The CCL2 Chemokine Promotes Early Seeding of the Latent HIV Reservoir
T. Packard, R. Schwarzer, … W. C. Greene·bioRxiv·Feb 25, 2021